| Q30561836 | (18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib. |
| Q34280032 | A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma |
| Q30490198 | A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas |
| Q36154339 | Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice |
| Q38297327 | Axon growth and guidance genes identify T-dependent germinal centre B cells |
| Q33588550 | Eef1a2 promotes cell growth, inhibits apoptosis and activates JAK/STAT and AKT signaling in mouse plasmacytomas |
| Q37414718 | Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma |
| Q36366548 | Extramedullary involvement in multiple myeloma |
| Q36321517 | Hematopoietic neoplasms in Prkar2a-deficient mice |
| Q33706389 | IL-6 and MYC collaborate in plasma cell tumor formation in mice |
| Q34254602 | Msh6 protects mature B cells from lymphoma by preserving genomic stability |
| Q33567153 | NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas |
| Q33779715 | Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis |
| Q37490002 | Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia. |
| Q91644110 | Wwox Deletion in Mouse B Cells Leads to Genomic Instability, Neoplastic Transformation, and Monoclonal Gammopathies |